Search
for
Sort by
Research 121–150 of 336
- Hair Removal Practices: A Literature Review.
- Lichen Planopilaris in Children: A Systematic Review
- Patterns of misdiagnosis in adults with alopecia areata: an analysis using the NIH 's <i>All of Us</i> database
- Mesenchymal Stem Cells for the Treatment of Skin Diseases
- Alopécie androgénogénétique chez la femme
- Female pattern hair loss
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- A First Case of Complete Resolution of Hair Loss in a Patient With Rheumatoid Arthritis and Concomitant Alopecia Universalis Treated With Filgotinib
- Biologics and small molecules for patients with concomitant alopecia areata and vitiligo: A review
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- Novel investigational drugs for alopecia areata and future perspectives
- The Gut and Skin Microbiome in Alopecia: Associations and Interventions.
- An evaluation of the available pharmacotherapy for the treatment of hirsutism
- Mesenchymal Stem Cells for Regenerative Medicine
- Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
- Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- Scarless wound healing: finding the right cells and signals
- Impact of estrogens in males and androgens in females
- Common skin infections in children
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine